Buchanan Ingersoll & Rooney’s Genevieve M. Spires Appointed Director of Communications and Technology for ABA Young Lawyers Division
Newark, N.J. – August 15, 2013 – Genevieve M. Spires, counsel in Buchanan Ingersoll & Rooney’s Food and Drug Administration & Pharmaceuticals section, has been appointed the Director of Communications and Technology for the American Bar Association Young Lawyers Division for the 2013-2014 bar year. Spires served as the Products Coordinator in this division for the 2012-13 bar year.
In addition to her active participation in the American Bar Association, Spires is also the Chair of the Publications Subcommittee of the Defense Research Institute’s Women in the Law Committee.
About Spires
Spires counsels life sciences companies on the laws and industry standards applicable to the sale and marketing of pharmaceuticals and medical devices. Her experience includes reviewing promotional materials and drafting sponsorship, consulting and other agreements.
She has been selected to the 2013 New Jersey Super Lawyers® Rising Stars list, which represents only the top 2.5 percent of lawyers in New Jersey.
About the Firm
Buchanan Ingersoll & Rooney PC (www.bipc.com) has nearly 450 attorneys and government relations professionals practicing throughout the United States, with multiple offices in Florida, New Jersey, New York and Pennsylvania, as well as offices in California, Delaware, North Carolina, Virginia and Washington, D.C.
- AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT
- ANTITRUST & TRADE REGULATION
- APPELLATE
- ATTORNEY UPDATE
- AUTONOMOUS & CONNECTED VEHICLES
- BANKRUPTCY & CREDITORS' RIGHTS
- BLOCKCHAIN & DIGITAL ASSETS
- BUCHANAN IP GUEST ASSOCIATE PROGRAM
- BUCHANAN LABS
- BUSINESS TAX
- CANNABIS
- CLASS ACTIONS
- COAL
- COMBINED HEAT & POWER (CHP)
- COMMERCIAL FINANCE
- CONSTRUCTION
- CONSUMER DEFENSE
- CONSUMER PRODUCTS
- CONTACT INFORMATION
- CONVERGENCE: M&A INSIGHTS IN HEALTHCARE
- COPYRIGHT
- CORONAVIRUS (COVID-19)
- CORPORATE
- CORPORATE COMPLIANCE
- CORPORATE TRANSPARENCY ACT
- CRIMINAL DEFENSE & GOVERNMENT ENFORCEMENT
- CYBERSECURITY & DATA PRIVACY
- DIVERSITY & INCLUSION
- DRUG TARGET ANALYSIS
- E-DISCOVERY
- EDUCATION
- EMERGING COMPANIES
- EMPLOYEE BENEFITS & ERISA
- EMPLOYMENT LITIGATION
- ENERGY
- ENTERTAINMENT, MEDIA & SPORTS
- ENVIRONMENTAL
- ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)
- ESTATES & TRUSTS
- EXECUTIVE COMPENSATION
- FAMILY OFFICE
- FDA & BIOTECHNOLOGY
- FINANCE
- FRANCHISE & DISTRIBUTION
- GOVERNMENT RELATIONS & PUBLIC POLICY
- HEALTHCARE
- HEALTHCARE ADMINISTRATIVE & JUDICIAL PROCEEDINGS
- HEALTHCARE INFORMATION SECURITY & PRIVACY
- HEALTHCARE LITIGATION
- HEALTHCARE REGULATORY & COMPLIANCE
- HEALTHCARE TRANSACTIONS
- HOSPITALITY
- HR & EMPLOYEE RELATIONS ISSUES
- IMMIGRATION
- INNOVATIVE HEALTHCARE DELIVERY & PAYMENT
- INSIDER INSIGHTS: 100 DAYS OF BIDEN
- INSURANCE & REINSURANCE
- INTELLECTUAL PROPERTY
- INTERNAL INVESTIGATIONS
- INTERNATIONAL SERVICES
- INTERNATIONAL TAX
- INTERNATIONAL TRADE & NATIONAL SECURITY
- IP LITIGATION
- LABOR & EMPLOYMENT
- LIFE SCIENCES
- LIFE SCIENCES LITIGATION
- LITIGATION
- MANUFACTURING
- MARITIME & ADMIRALTY
- MATRIMONIAL & FAMILY LAW
- MERGERS & ACQUISITIONS
- NATIONAL SECURITY EXPORT CONTROLS AND ECONOMIC SANCTIONS
- NONPROFIT ORGANIZATIONS
- OIL & GAS
- OPPORTUNITY ZONES
- PASS-THROUGH ENTITIES
- PATENT COUNSELING & STRATEGIC ADVICE
- PATENT OFFICE LITIGATION
- PATENT PROCUREMENT
- POST-ACUTE & LONG-TERM CARE
- POWER GENERATION & UTILITY
- PRIVATE EQUITY AND VENTURE CAPITAL
- PRODUCT LIABILITY
- PUBLIC FINANCE
- PUBLIC PROCUREMENT & BID PROTESTS
- REAL ESTATE
- REAL ESTATE FINANCE
- REAL ESTATE TRANSACTIONS
- REIMBURSEMENT & MANAGED CARE
- RENEWABLES AND ALTERNATIVE ENERGY
- SECURITIES & SEC
- SECURITY ALARM
- SPORTS
- STATE & LOCAL TAX
- TAX
- TAX CONTROVERSY
- TECHNOLOGY, LICENSING AND COMMERCIAL CONTRACTS
- TITLE IX
- TRADE REMEDIES
- TRADE SECRETS & RESTRICTIVE COVENANTS